Form 4: Life360 Director Chris Hulls Exercises Options, Sells Shares
Insider Transaction Report
Life360 Director Chris Hulls reported exercising stock options and selling a significant number of common shares in late November 2025.
Summary
- Chris Hulls, a Director of Life360, Inc., engaged in multiple transactions involving the company's common stock on November 25 and 26, 2025.
- Hulls exercised stock options to acquire a total of 352,984 shares of common stock across three transactions: 208,987 shares at $2.15, 95,833 shares at $13.35, and 48,164 shares at $8.19.
- He subsequently sold a total of 431,749 shares of common stock in five separate transactions, with weighted average prices ranging from $76.91 to $79.11 per share.
- Additionally, Hulls made a bona fide gift of 62,500 shares of common stock to a donor-advised fund for charitable purposes.
- Following these transactions, Hulls directly beneficially owns 335,413 shares of common stock.
- Indirect beneficial ownership includes 195,312 shares each held by three separate irrevocable trusts (Robin Hulls 2023 Irrevocable Trust, Rose Hulls 2023 Irrevocable Trust, Mckenzie Hulls 2023 Irrevocable Trust) and 1,846 shares representing his proportionate interest in ICCA Labs, LLC.
- Remaining derivative securities include 4,167 stock options exercisable at $13.35 and 233,801 stock options exercisable at $8.19.
Sentiment
Score: 6
Explanation: The filing details significant insider transactions where a director exercised options and sold shares at high prices, indicating personal financial gain. While the sales reduce direct beneficial ownership, they are often part of pre-planned diversification or liquidity strategies and do not necessarily reflect a negative outlook on the company. The charitable gift is also a positive personal action.
Positives
- Director Chris Hulls exercised options at significantly lower prices ($2.15, $13.35, $8.19) compared to the sale prices ($76.91 to $79.11), indicating substantial personal gain.
- The sales occurred at high share prices, reflecting a strong market valuation for Life360 stock at the time of the transactions.
- A charitable gift of 62,500 shares was made, which can have positive tax implications for the donor and reflects philanthropic activity.
Negatives
- Director Chris Hulls sold a substantial number of shares (431,749 shares) over two days, which could be interpreted by some investors as a reduction in direct exposure to the company's future performance.
- The gift of 62,500 shares also reduces the director's direct beneficial ownership.
Future Outlook
NA
Industry Context
This Form 4 filing details routine insider transactions by a director, which are common across all industries for executives managing their personal equity holdings, often for diversification, liquidity, or tax planning purposes. It does not provide specific insights into broader industry trends for location-based services or social networking companies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Correction of Filing Error | The vesting terms for a stock option with an exercise price of $8.19 were inadvertently misreported on a previous Form 3/A filed on July 20, 2022, and have been corrected in this Form 4. | 2025-11-26 | This correction ensures accuracy in the public record regarding director compensation and equity holdings, improving transparency. |
Stakeholder Impact
- Shareholders: The sale of a significant number of shares by a director could be viewed with mixed sentiment; some may see it as a director taking profits, while others might interpret it as a reduction in confidence, though often it's for personal financial planning. The high sale prices could be seen as a positive indicator of current valuation.
Next Steps
- The Reporting Person undertakes to provide full details regarding the number of shares sold at each separate price within the reported ranges upon request to the Issuer, any securityholder, or the SEC Staff.
Key Dates
| Date | Description |
|---|---|
| 2022-02-01 | Start date for monthly vesting of stock option with an exercise price of $8.19. |
| 2022-07-20 | Date of original Form 3/A filing where vesting terms for a stock option were inadvertently misreported. |
| 2025-10-24 | Expiration date for stock option with an exercise price of $2.15. |
| 2025-11-25 | Date of earliest transaction, including option exercises, share sales, and a charitable gift. |
| 2025-11-26 | Date of additional option exercises and share sales. |
| 2027-02-01 | Expiration date for stock option with an exercise price of $13.35. |
| 2028-05-20 | Expiration date for stock option with an exercise price of $8.19. |
Recommendation
holdThe filing primarily details a director's personal equity management, including exercising options and selling shares at favorable prices. While the sales reduce the director's direct stake, they are often pre-planned and do not inherently signal a change in the company's fundamental outlook. Without additional company-specific financial or operational news, this filing alone does not provide a strong basis for a "buy" or "sell" recommendation for the stock, suggesting a "hold" position is appropriate for investors awaiting broader company updates.
Keywords
Life360, LIF, Chris Hulls, Director, Insider Trading, Stock Options, Share Sale, Beneficial Ownership, SEC Form 4, Equity Transactions, Charitable Gift
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.